跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 224 条关于
“GTRI”
全部
224
临床试验
118
药物
73
机构
13
资讯
20
4个月前
US Maintains Pressure on India's Pharmaceutical Patent System Through Priority Watch List Designation
去年
India-UK Free Trade Agreement Raises Concerns Over Access to Affordable Medicines
9个月前
GRI Bio's GRI-0621 Shows Promise in Phase 2a IPF Trial with Disease-Modifying Potential
3个月前
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
去年
GRI Bio Advances Phase 2a Trial of GRI-0621 for Idiopathic Pulmonary Fibrosis with Promising Interim Safety Data
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
12个月前
ExSight Ventures Backs RevOpsis Therapeutics' Novel Tri-Specific Antibody Platform for Retinal Diseases
16天前
Purple Biotech Secures U.S. Patent Allowance for CAPTN-3 Tri-Specific Antibody Platform
去年
Doer Biologics Completes Phase 2 Enrollment for Novel Tri-Specific Agonist Targeting Severe Hypertriglyceridemia
7个月前
GRI Bio Secures Patent Protection for Novel NKT Cell-Targeting Compounds Across Inflammatory Diseases
第 1 页,共 2 页
上一页
下一页